What is the initial management of Acute Respiratory Distress Syndrome (ARDS) in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Management of Pediatric Acute Respiratory Distress Syndrome (PARDS)

Immediately implement lung-protective mechanical ventilation with tidal volumes of 4-8 mL/kg predicted body weight (not actual body weight) and maintain plateau pressures ≤30 cmH₂O as the cornerstone of PARDS management. 1, 2

Immediate Assessment and Respiratory Support Decision

Consider Non-Invasive Ventilation First (Selected Patients Only)

  • A trial of non-invasive ventilation (NIV) or high-flow nasal cannula may be attempted only in children without clear intubation indications who are responding to initial resuscitation. 1, 2
  • Reassess the patient's condition carefully and frequently within 1 hour of NIV initiation—do not delay intubation if deterioration occurs, as this is associated with worse outcomes. 2, 3
  • Contraindications to NIV include impaired consciousness, inability to protect airway, hemodynamic instability, copious secretions, or multi-organ failure. 3

Proceed to Intubation for Most Patients

  • Most children with PARDS require intubation in a controlled setting rather than emergent intubation. 3
  • Avoid etomidate when intubating children with septic shock or sepsis-associated organ dysfunction. 1

Lung-Protective Mechanical Ventilation Parameters

Tidal Volume

  • Set tidal volume at 4-8 mL/kg predicted body weight—never use actual body weight for calculations. 1, 2
  • This is the only strategy that has consistently improved outcomes in ARDS. 4
  • Studies show that over 25% of pediatric ARDS patients are still ventilated with tidal volumes above 10 mL/kg in actual practice, which must be avoided. 5

Plateau Pressure

  • Limit plateau pressure to ≤28-30 cmH₂O in most cases. 1, 2
  • In restrictive lung disease with increased chest wall elastance, plateau pressures up to 29-32 cmH₂O may be acceptable. 1
  • Plateau pressures should be checked regularly and never exceed 30 cmH₂O. 1, 2

Positive End-Expiratory Pressure (PEEP)

  • Use higher PEEP in moderate-to-severe PARDS, guided by the ARDS-network PEEP-to-FiO₂ grid. 1, 2, 3
  • Start with PEEP ≥12 cmH₂O in severe cases. 1
  • The exact level of high PEEP has not been definitively determined in PARDS patients, but avoid limiting PEEP to ~10 cmH₂O as oxygenation worsens—this is a common pitfall. 6
  • Be aware that adverse hemodynamic effects of high PEEP may be more prominent in children with septic shock. 1

Inspiratory Time and Respiratory Rate

  • Set inspiratory time and respiratory rate based on respiratory system mechanics and disease trajectory—these parameters are closely correlated. 1
  • In restrictive lung disease, use a higher respiratory rate to compensate for low tidal volume and maintain minute ventilation. 1
  • Avoid flow end-inspiratory or expiratory flow interruption to prevent air-trapping. 1

Oxygenation and Ventilation Targets

Oxygenation Goals

  • Target SpO₂ 92-96% to avoid oxygen toxicity—do not target higher saturations. 2, 3
  • Target PaO₂ 70-90 mmHg. 2
  • Permissive mild hypoxemia (SpO₂ as low as 88%) is tolerable in many cases. 5

Ventilation Goals

  • Accept permissive hypercapnia with pH as low as 7.20 for ≥6 hours if necessary to maintain lung-protective ventilation. 1
  • Many pediatric intensivists consider permissive hypercapnia tolerable. 5

Sedation and Spontaneous Breathing

Sedation Strategy

  • Sedation should be titrated according to local protocols, including regular drug interruption. 1
  • As oxygenation improves and FiO₂/PEEP can be reduced, stop or reduce sedation and assess for weaning readiness. 1

Spontaneous Breathing

  • All children on respiratory support should preferably breathe spontaneously, except the most severely ill children requiring very high ventilator settings. 1
  • In severely ill children with restrictive, obstructive, or mixed disease requiring very high settings, use controlled mechanical ventilation with continuous sedation and/or muscle relaxants. 1
  • Partial ventilatory support requires less sedation and can reduce ventilation-perfusion mismatch, but patient-ventilator synchrony is paramount. 1

Adjunctive Therapies for Severe PARDS

Prone Positioning

  • Implement prone positioning for at least 12 hours per day in children with severe PARDS (PaO₂/FiO₂ <100 mmHg). 1, 2, 7
  • This intervention has demonstrated significant mortality reduction in severe ARDS. 3
  • Apply deep sedation and analgesia during prone positioning. 3

Neuromuscular Blockade

  • Consider neuromuscular blockade for 24-48 hours after ARDS onset in severe PARDS to improve ventilator synchrony and reduce oxygen consumption. 1, 2, 7
  • Cisatracurium infusion for 48 hours in early severe ARDS is particularly beneficial when ventilator-patient dyssynchrony persists despite sedation. 3
  • Caution is advised when using sedation and relaxation in the presence of cardiac dysfunction. 1

Recruitment Maneuvers

  • No definitive recommendation can be made for or against recruitment maneuvers in children with PARDS and refractory hypoxemia. 1
  • If a recruitment maneuver is considered, use a stepwise, incremental and decremental PEEP titration maneuver rather than sustained inflation techniques. 1
  • All PARDS patients must be carefully monitored for tolerance of the maneuver. 1

Inhaled Nitric Oxide (iNO)

  • Do not routinely use iNO in all children with sepsis-induced PARDS. 1, 7
  • Consider iNO as rescue therapy only in children with PARDS and refractory hypoxemia after other oxygenation strategies have been optimized. 1, 7
  • Discontinue if no rapid improvement in oxygenation occurs. 3

High-Frequency Oscillatory Ventilation (HFOV)

  • Do not routinely use HFOV in patients with moderate or severe ARDS. 1
  • HFOV may be considered if conventional ventilation fails, using an open lung strategy to maintain optimal lung volume. 1
  • A mortality benefit of HFOV in acute hypoxemic respiratory failure has not been shown. 1
  • HFOV should not be used in obstructive airway disease because of the risk of dynamic hyperinflation. 1

Fluid Management

  • Implement conservative fluid management once respiratory status is stabilized to minimize pulmonary edema while maintaining adequate organ perfusion. 2, 7, 3
  • Monitor fluid balance carefully—excessive fluid administration worsens oxygenation, promotes right ventricular failure, and increases mortality. 3
  • Accurate recording of fluid intake and output is important. 1

Monitoring Requirements

Continuous Monitoring

  • Continuously monitor oxygen saturation, respiratory mechanics, and hemodynamics to promptly identify deterioration. 2, 3
  • Monitor for ventilator-patient dyssynchrony. 3

Echocardiography

  • Assess right ventricular function via echocardiography, as RV failure significantly worsens outcomes. 2, 3
  • Repeated echocardiography is essential during management. 1

Blood Gas Monitoring

  • Arterial blood gas analysis should be performed at 1-2 hours and again at 4-6 hours if initial improvement is minimal. 3

Advanced Rescue Therapies

Extracorporeal Membrane Oxygenation (ECMO)

  • Consider venovenous ECMO (VV-ECMO) only at centers with ECMO expertise for patients with severe ARDS failing conventional management, particularly those with potentially reversible disease. 1, 2, 3
  • VV-ECMO is indicated in patients with severe ARDS within 7 days after onset with persistent life-threatening hypoxemia (PaO₂/FiO₂ <70 for ≥3 hours or <100 for ≥6 hours) unresponsive to optimized supportive therapy. 1
  • If no ECMO is available, early consultation of an ECMO center is recommended because transporting patients who need ECMO can be hazardous. 1
  • All ECMO techniques carry hemodynamic risks and require expertise, experience, and an interdisciplinary approach. 1

Common Pitfalls to Avoid

  • Never use actual body weight for tidal volume calculations—always use predicted body weight. 2, 3
  • Do not limit PEEP to ~10 cmH₂O as oxygenation worsens—this is inadequate in moderate-to-severe PARDS. 6
  • Do not delay intubation in patients failing NIV—this is associated with worse outcomes. 2, 3
  • Do not target SpO₂ higher than 96%—this increases oxygen toxicity risk. 3
  • Do not tolerate plateau pressures above 30 cmH₂O. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Pediatric Acute Respiratory Distress Syndrome (PARDS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ARDS Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute respiratory distress syndrome.

Indian pediatrics, 2010

Research

Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2013

Research

Variability in Usual Care Mechanical Ventilation for Pediatric Acute Respiratory Distress Syndrome: Time for a Decision Support Protocol?

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2017

Guideline

Evidence for SMOF Lipid in Pediatric ARDS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.